Peptide-specific ctl in tumor-infiltrating lymphocytes from metastatic melanomas expressing mart-1/melan-a, gp100 and tyrosinase genes: A study in an unselected group of hla-a2.1-positive patients-Reference-Cited by-同舟云学术

Peptide-specific ctl in tumor-infiltrating lymphocytes from metastatic melanomas expressing mart-1/melan-a, gp100 and tyrosinase genes: A study in an unselected group of hla-a2.1-positive patients

Published:1995-10-20 Issue:5 Volume:64 Page:309-315
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Spagnoli Giulio C.,Schaefer Christoph,Willimann Thomas E.,Kocher Thomas,Amoroso Antonio,Juretic Antonio,Zuber Markus,Luscher Urs,Harder Felix,Heberer Michael

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference22 articles.

1. Solid phase peptide synthesis using Nα-fluorenylmethoxycarbonylamino acid pentafluorophenyl esters

2. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.

3. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.

4. Costimulation of T cells for tumor immunity

5. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The peptide woods are lovely, dark and deep: Hunting for novel cancer antigens;Seminars in Immunology;2023-05

2. Cellular therapy approaches harnessing the power of the immune system for personalized cancer treatment;Seminars in Immunology;2019-04

3. Functional features of cancer stem cells in melanoma cell lines;Cancer Cell International;2013

4. Preclinical Qualification of a New Multi-antigen Candidate Vaccine for Metastatic Melanoma;Journal of Immunotherapy;2010-10

5. The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines;Cancer Immunology, Immunotherapy;2008-10-01